Drug
Herpes Zoster Vaccine Gsk1437173a
Herpes Zoster Vaccine Gsk1437173a: highest development phase Phase 3, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Herpes Zoster Vaccine GSK1437173A NCT02723773 | Phase 3 | Herpes Zoster |
Latest
No recent events.
Follow Herpes Zoster Vaccine Gsk1437173a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.